Role of the posterior mucosal defense barrier in portal hypertensive gastropathy

Portal hypertensive gastropathy (PHG) is a complication of cirrhotic or noncirrhotic portal hypertension. PHG is very important in the clinic because it can cause acute or even massive blood loss, and its treatment efficacy and prognosis are poor. Currently, the incidence of PHG in patients with cir...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhiqiang Yi, Minglin Zhang, Zhiyuan Ma, Biguang Tuo, Aimin Liu, Zilin Deng, Yingying Zhao, Taolang Li, Xuemei Liu
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/1033f5060d8b43969c4dd9e8ab44e855
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1033f5060d8b43969c4dd9e8ab44e855
record_format dspace
spelling oai:doaj.org-article:1033f5060d8b43969c4dd9e8ab44e8552021-11-14T04:28:55ZRole of the posterior mucosal defense barrier in portal hypertensive gastropathy0753-332210.1016/j.biopha.2021.112258https://doaj.org/article/1033f5060d8b43969c4dd9e8ab44e8552021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221010428https://doaj.org/toc/0753-3322Portal hypertensive gastropathy (PHG) is a complication of cirrhotic or noncirrhotic portal hypertension. PHG is very important in the clinic because it can cause acute or even massive blood loss, and its treatment efficacy and prognosis are poor. Currently, the incidence of PHG in patients with cirrhosis is 20–80%, but its pathogenesis is complicated and poorly understood. Studies have shown that portal hypertension can cause changes in gastric mucosal microcirculation hemodynamics, leading to changes in gastric mucosal histology and function and thereby weakening the mucosal defense barrier. However, no specific drug treatment plans are currently available. This article reviews the current literature to further our understanding of the mechanism underlying PHG and the relationship between PHG and the posterior mucosal defense barrier and to explore new therapeutic targets.Zhiqiang YiMinglin ZhangZhiyuan MaBiguang TuoAimin LiuZilin DengYingying ZhaoTaolang LiXuemei LiuElsevierarticlePortal hypertensive gastropathyPosterior mucosal defense barrierMicrovascular endothelial cellsIschemia-reperfusion injuryEndothelial cell dysfunctionEndothelial cell moleculesTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112258- (2021)
institution DOAJ
collection DOAJ
language EN
topic Portal hypertensive gastropathy
Posterior mucosal defense barrier
Microvascular endothelial cells
Ischemia-reperfusion injury
Endothelial cell dysfunction
Endothelial cell molecules
Therapeutics. Pharmacology
RM1-950
spellingShingle Portal hypertensive gastropathy
Posterior mucosal defense barrier
Microvascular endothelial cells
Ischemia-reperfusion injury
Endothelial cell dysfunction
Endothelial cell molecules
Therapeutics. Pharmacology
RM1-950
Zhiqiang Yi
Minglin Zhang
Zhiyuan Ma
Biguang Tuo
Aimin Liu
Zilin Deng
Yingying Zhao
Taolang Li
Xuemei Liu
Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
description Portal hypertensive gastropathy (PHG) is a complication of cirrhotic or noncirrhotic portal hypertension. PHG is very important in the clinic because it can cause acute or even massive blood loss, and its treatment efficacy and prognosis are poor. Currently, the incidence of PHG in patients with cirrhosis is 20–80%, but its pathogenesis is complicated and poorly understood. Studies have shown that portal hypertension can cause changes in gastric mucosal microcirculation hemodynamics, leading to changes in gastric mucosal histology and function and thereby weakening the mucosal defense barrier. However, no specific drug treatment plans are currently available. This article reviews the current literature to further our understanding of the mechanism underlying PHG and the relationship between PHG and the posterior mucosal defense barrier and to explore new therapeutic targets.
format article
author Zhiqiang Yi
Minglin Zhang
Zhiyuan Ma
Biguang Tuo
Aimin Liu
Zilin Deng
Yingying Zhao
Taolang Li
Xuemei Liu
author_facet Zhiqiang Yi
Minglin Zhang
Zhiyuan Ma
Biguang Tuo
Aimin Liu
Zilin Deng
Yingying Zhao
Taolang Li
Xuemei Liu
author_sort Zhiqiang Yi
title Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
title_short Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
title_full Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
title_fullStr Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
title_full_unstemmed Role of the posterior mucosal defense barrier in portal hypertensive gastropathy
title_sort role of the posterior mucosal defense barrier in portal hypertensive gastropathy
publisher Elsevier
publishDate 2021
url https://doaj.org/article/1033f5060d8b43969c4dd9e8ab44e855
work_keys_str_mv AT zhiqiangyi roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT minglinzhang roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT zhiyuanma roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT biguangtuo roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT aiminliu roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT zilindeng roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT yingyingzhao roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT taolangli roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
AT xuemeiliu roleoftheposteriormucosaldefensebarrierinportalhypertensivegastropathy
_version_ 1718430000157294592